CIBC World Market
SPHS

CIBC World Market’s Sophiris Bio, Inc. SPHS Stock Holding History

CIBC World Market’s Portfolio SPHS Stock Details SPHS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-11,446
Closed -$32K – 1265
2018
Q3 		$32K Hold
11,446
– – ﹤0.01% 1114
2018
Q2 		$32K Sell
11,446
-480
-4% -$1.43K ﹤0.01% 1125
2018
Q1 		$24K Buy
+11,926
New +$25.8K ﹤0.01% 1140

Other funds holding SPHS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HP
Hikari Power Tokyo, Japan $1.15B AUM 5.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BO
BRR OpCo Columbus, Ohio $814M AUM 9.75% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

CIBC World Market's SPHS Position: Q4 2018 in Review

CIBC World Market sold out of Sophiris Bio, Inc. (SPHS) in Q4 2018, closing a stake of 11,446 shares — an estimated $32K sold.

CIBC World Market first reported a position in SPHS in Q1 2018 and held it in 3 quarters. The position peaked at $32K in Q3 2018. 31 funds tracked by Wall St. Rank hold SPHS as of Q4 2018.

  • CIBC World Market reported no remaining Sophiris Bio, Inc. position as of Q4 2018 after selling out during the quarter.
  • CIBC World Market sold 11,446 Sophiris Bio, Inc. shares in Q4 2018, an estimated $32K.
  • CIBC World Market first reported a position in Sophiris Bio, Inc. in Q1 2018 and held it in 3 quarters.
  • CIBC World Market's Sophiris Bio, Inc. position peaked at $32K in Q3 2018.
  • 31 funds tracked by Wall St. Rank held Sophiris Bio, Inc. as of Q4 2018.

Based on CIBC World Market's 13F filing for Q4 2018, filed 13 Feb 2019.